Singapore: Launch of the Health Appointment System to encourage vaccination of more adult Singaporeans

In brief

Open Government Products, a governmental technology agency, is launching the Health Appointment System ("HAS") in mid-August 2022. The HAS is a platform that will enable doctors to offer vaccine appointment slots at their clinics to patients.

Through the HAS, the government seeks to increase the accessibility of vaccinations in Singapore and to encourage more Singaporeans to get vaccinated, as well as to provide an easy-to-use system for clinics to adopt.  


Contents

In more detail

Background

In response to the severity of pneumonia cases within Singapore, Open Government Products has developed the HAS to address this issue. Pneumonia is the third-leading cause of death in Singapore, but is highly preventable via pneumococcal and flu vaccines. However, less than 10% of Singaporeans above the age of 65 have received both doses of their pneumococcal vaccines.

One of the key reasons for this statistic is accessibility. Singaporeans may not know where to sign up for such vaccinations or whether they can even get an appointment.

Increasing accessibility through the HAS

The HAS facilitates access to vaccinations and enhances the ease of booking appointments.

More specifically, the HAS will link Community Health Assist Scheme ("CHAS") GP clinics with patients who are interested in taking vaccines under the National Adult Immunization Schedule ("NAIS"). For the initial launch, the government intends to target the vulnerable elderly, and intends to reach out to more than 600,000 eligible elderly to take their CHAS-subsidized pneumococcal vaccines (i.e., PCV13 and PPSV23) through the HAS.

After the initial roll-out, the government may gradually expand the ambit of vaccinations under the HAS to include other NAIS vaccines.

Adopting the HAS platform

Open Government Products has sought to make the HAS platform user-friendly for clinics to adopt, where clinics would have full control over the availability of appointment slots with minimal administration required.

Key benefits of the HAS for clinics include a potential growth in the clinic's patient base; and to allow clinics to better manage and plan their vaccine supply. It also offers clinics the opportunity to be part of the national effort to  boost immunisation levels of vulnerable Singaporeans and to generally strengthen Singapore's public health system.

Clinics are invited to enroll in the HAS in the lead up to the public launch on 14 August.

 

The FAQs on the HAS may be accessed here.

 

LOGO_Wong&Leow_Singapore

© 2022 Baker & McKenzie.Wong & Leow. All rights reserved. Baker & McKenzie.Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.